Nisa Investment Advisors’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.19K Hold
342
﹤0.01% 2602
2025
Q4
$2.04K Hold
342
﹤0.01% 2608
2025
Q3
$1.82K Hold
342
﹤0.01% 2639
2025
Q2
$1.17K Sell
342
-75
-18% -$239 ﹤0.01% 2703
2025
Q1
$1.23K Sell
417
-79
-16% -$247 ﹤0.01% 2579
2024
Q4
$1.51K Buy
496
+370
+294% +$1.08K ﹤0.01% 2574
2024
Q3
$321 Buy
+126
New +$381 ﹤0.01% 2793
2020
Q4
Sell
-350
Closed -$4K 2329
2020
Q3
$4K Hold
350
﹤0.01% 2210
2020
Q2
$4K Hold
350
﹤0.01% 2023
2020
Q1
$3K Sell
350
-34,790
-99% -$338K ﹤0.01% 2010
2019
Q4
$307K Buy
35,140
+35,000
+25,000% +$290K ﹤0.01% 1226
2019
Q3
$2K Hold
140
﹤0.01% 1982
2019
Q2
$2K Hold
140
﹤0.01% 1978
2019
Q1
$5K Hold
140
﹤0.01% 1913
2018
Q4
$3K Hold
140
﹤0.01% 1879
2018
Q3
$6K Sell
140
-70
-33% -$3.38K ﹤0.01% 1851
2018
Q2
$12K Buy
210
+50
+31% +$2.9K ﹤0.01% 1676
2018
Q1
$11K Sell
160
-50
-24% -$3.74K ﹤0.01% 1630
2017
Q4
$21K Hold
210
﹤0.01% 1540
2017
Q3
$25K Hold
210
﹤0.01% 1490
2017
Q2
$18K Buy
210
+50
+31% +$2.8K ﹤0.01% 1521
2017
Q1
$6K Sell
160
-140
-47% -$5.11K ﹤0.01% 1786
2016
Q4
$9K Buy
+300
New +$13K ﹤0.01% 1819
2016
Q2
Sell
-300
Closed -$9K 1880
2016
Q1
$9K Buy
+300
New +$13.6K ﹤0.01% 1789

Other funds holding PBYI

Nisa Investment Advisors's PBYI Position: Q1 2026 in Review

Nisa Investment Advisors held its Puma Biotechnology (PBYI) position steady in Q1 2026 at 342 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

Nisa Investment Advisors first reported a position in PBYI in Q1 2016 and has held it in 24 quarters since. The position peaked at $307K in Q4 2019. 157 funds tracked by Wall St. Rank hold PBYI as of Q1 2026.

  • Nisa Investment Advisors held 342 shares of Puma Biotechnology worth $2.19K as of Q1 2026.
  • Nisa Investment Advisors left its Puma Biotechnology share count unchanged in Q1 2026.
  • Puma Biotechnology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2602 holding.
  • Nisa Investment Advisors first reported a position in Puma Biotechnology in Q1 2016 and has held it in 24 quarters since.
  • Nisa Investment Advisors's Puma Biotechnology position peaked at $307K in Q4 2019.
  • 157 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.